April 19, 2026 a 11:43 am
ELV: Fundamental Ratio Analysis - Elevance Health Inc.
Elevance Health Inc. is a resilient player in the healthcare sector, showing robust fundamentals and a commendable market position. The company's focus on health benefits offers a diverse portfolio, catering to the needs of millions. With a solid foundation and continued growth potential, its stock presents an attractive opportunity for investors.
Fundamental Rating
The fundamental evaluation of Elevance Health Inc. suggests a strong standing with an overall rating of A-. The detailed scores reflect the company's strategic initiatives and market confidence.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 3 |
Historical Rating
The historical ratings indicate consistency in Elevance Health Inc.'s fundamental scores over recent periods, showing a stable investment outlook.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | 4 | 5 | 4 | 5 | 1 | 3 | 3 |
| 2026-04-19 | 4 | 5 | 4 | 5 | 1 | 3 | 3 |
Analyst Price Targets
Analysts set high expectations for ELV with price targets reflecting a growth trajectory, underscored by median and consensus figures showing confidence.
| High | Low | Median | Consensus |
|---|---|---|---|
| $425 | $332 | $393 | $385.69 |
Analyst Sentiment
Analyst sentiment is predominantly positive for Elevance Health Inc., with majority buy recommendations reflecting a strong market consensus.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 26 | |
| Hold | 11 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Elevance Health Inc. presents a strong investment case with solid fundamentals and a supportive analyst sentiment. The company benefits from a diverse portfolio and a significant market presence, catering to a broad customer base. While the high expectations in analyst targets indicate promising growth potential, investors should consider the broader economic conditions and healthcare policy changes. Nevertheless, the company's robust fundamentals provide a good cushion against potential market fluctuations.